Loading...
XHKG
1931
Market cap132mUSD
Jul 10, Last price  
0.65HKD
1D
0.00%
1Q
-44.44%
IPO
-78.83%
Name

Ivd Medical Holding Ltd

Chart & Performance

D1W1MN
XHKG:1931 chart
P/E
25.80
P/S
0.32
EPS
0.02
Div Yield, %
19.10%
Shrs. gr., 5y
3.90%
Rev. gr., 5y
3.04%
Revenues
2.82b
-10.81%
290,441,000338,268,000413,635,0002,332,740,0002,428,210,0002,730,670,0002,748,809,0003,088,387,0003,162,415,0002,820,663,000
Net income
35m
-86.59%
56,268,000110,735,000103,440,000275,001,000158,718,000174,541,000209,999,000238,163,000260,420,00034,933,000
CFO
-919m
L
-23,519,00019,717,0001,959,000340,716,000170,494,000163,108,000249,671,000292,424,000140,287,000-918,887,000
Dividend
Jul 15, 20240.06209 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

IVD Medical Holding Limited functions as an investment holding company primarily engaged in the distribution of in vitro diagnostic (IVD) products. Its operations span both Mainland China and global markets. The enterprise structures its activities into three key segments: a Distribution Business, Maintenance Services, and a Self-branded Products Business. The company offers a comprehensive range of IVD analysers, reagents, and other consumables. These are utilized across various diagnostic testing fields, including hematology and body fluid analysis, immunoassay, clinical chemistry, molecular diagnostics, microbiology, and point-of-care testing. Additionally, it supplies haemostasis products and provides specialized solution services for clinical laboratories within hospitals. Its maintenance services include repair, installation, and training for end customers. Under its proprietary IVD brand, the company actively researches, develops, manufactures, and markets IVD analyzers and reagents. Its clientele encompasses hospitals, various healthcare institutions, logistics partners, and independent distributors. Established in 1993, IVD Medical Holding Limited maintains its headquarters in Shanghai, People's Republic of China.
IPO date
Jul 12, 2019
Employees
779
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT